RecruitingPhase not listedNCT06433752A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)Sponsor: TG Therapeutics, Inc.Golden Valley, MN · Plymouth, MN · +107 more sites
RecruitingPhase 3NCT05877963Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabSponsor: TG Therapeutics, Inc.Golden Valley, MN · Plymouth, MN · +39 more sites
RecruitingNot applicableNCT06796504The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot StudySponsor: SetPoint Medical CorporationPlymouth, MN · +8 more sites